(BUSINESS WIRE)–Jan. 29, 2015– Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will provide an overview of the company at the Leerink Global Healthcare Conference taking place February 11-12 in New York. The Exelixis presentation is scheduled for 11:30 a.m. EST/8:30 a.m. PST on Wednesday, February 11, 2015. The presentation will be webcast live and may be accessed via the Event Calendar page under Investors & Media at www.exelixis.com.
Shares of Exelixis opened today at $2.05 and are currently trading down at $1.96. EXEL has a 1-year high of $7.58 and a 1-year low of $1.26. The stock’s 50-day moving average is $1.54 and it’s 200-day moving average is $2.23.
Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.